Corrigendum to “MeCP2 promotes gastric cancer progression through regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 signaling pathways” [EBioMedicine 16 (2017) 87–100, (S2352396417300257), (10.1016/j.ebiom.2017.01.021)]

  • Lingyu Zhao
  • , Yingxun Liu
  • , Dongdong Tong
  • , Yannan Qin
  • , Juan Yang
  • , Meng Xue
  • , Ning Du
  • , Liying Liu
  • , Bo Guo
  • , Ni Hou
  • , Jia Han
  • , Siyuan Liu
  • , Na Liu
  • , Xiaoge Zhao
  • , Lumin Wang
  • , Yanke Chen
  • , Chen Huang

Research output: Contribution to journalComment/debate

Abstract

The authors found that the published version of this article had an error in Fig. 1I. The annotations did not match the number of lanes of the WB blots. The figure showed MeCP2 protein expressions in 4 pairs of GC tissues. The unintentional mistake was made because incorrect pictures were selected when editing PDF image files. We have presented the corrected Fig. 1 I as below. The correction does not change the description and original conclusions of this article. The authors sincerely apologize for any inconvenience caused by this mistake.

Original languageEnglish
Article number104579
JournaleBioMedicine
Volume91
DOIs
StatePublished - May 2023

Fingerprint

Dive into the research topics of 'Corrigendum to “MeCP2 promotes gastric cancer progression through regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 signaling pathways” [EBioMedicine 16 (2017) 87–100, (S2352396417300257), (10.1016/j.ebiom.2017.01.021)]'. Together they form a unique fingerprint.

Cite this